单位：[1]Shanghai Chest Hosp, Shanghai Lung Tumor Clin Ctr, Shanghai, Peoples R China[2]GGH, Dept Clin Oncol, Guangzhou, Guangdong, Peoples R China[3]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China广东省人民医院[4]Beijing Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China[5]Shanxi Canc Hosp, Dept Resp Dis 2, Taiyuan, Peoples R China[6]China Janpan Friendship Hosp, Oncol Dept Integrat Med, Beijing, Peoples R China[7]Heilongjiang Canc Hosp, Dept Med Oncol, Harbin, Peoples R China[8]Liaoning Canc Hosp, Dept Med Oncol, Shenyang, Peoples R China[9]Jiangsu Prov Hosp, Dept Med Oncol, Nanjing, Peoples R China江苏省人民医院[10]Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China[11]301 Mil Hosp, Dept Med Oncol, Beijing, Peoples R China
第一作者单位：[1]Shanghai Chest Hosp, Shanghai Lung Tumor Clin Ctr, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Lu S.,Wu Y. L.,Wang Y. Z.,et al.DOCETAXEL REGIMEN AS SECOND-LINE TREATMENT FOR PRETREATED ADVANCED NSCLC PATIENTS - A LARGE-SCALE, MULTICENTER, UNCONTROLLED, REGISTRY STUDY IN CHINA[J].ANNALS of ONCOLOGY.2012,23:438-438.
APA：
Lu, S.,Wu, Y. L.,Wang, Y. Z.,Song, X.,Jia, L. Q....&Zhao, H..(2012).DOCETAXEL REGIMEN AS SECOND-LINE TREATMENT FOR PRETREATED ADVANCED NSCLC PATIENTS - A LARGE-SCALE, MULTICENTER, UNCONTROLLED, REGISTRY STUDY IN CHINA.ANNALS of ONCOLOGY,23,
MLA：
Lu, S.,et al."DOCETAXEL REGIMEN AS SECOND-LINE TREATMENT FOR PRETREATED ADVANCED NSCLC PATIENTS - A LARGE-SCALE, MULTICENTER, UNCONTROLLED, REGISTRY STUDY IN CHINA".ANNALS of ONCOLOGY 23.(2012):438-438
医学